Cytogenetic analysis of childhood acute lymphoblastic leukemia

OBJECTIVE: To characterize the genetic aberrations in pediatric acute lymphoblastic leukemia (ALL).

METHODS: Ninety ALL cases were enrolled in the study from January 2009 to November 2011. Chromosome banding analysis and fluorescence in situ hybridization (FISH) were used to detect genetic aberrations.

RESULTS: (1) Chromosome analysis: 35 (53.0%) of 66 cases who had metaphase were abnormal, and 24 cases had no metaphase. (2) FISH analysis: among the 31 cases who had normal karyotypes and 24 who had no metaphase detected by chromosome banding technique, 7 (22.6%) and 14 (58.3%) cases were abnormal detected by FISH, respectively. There were no statistically significant differences compared with chromosome analysis (P = 0.655). Among these 55 ALL cases TEL/AML1, bcr-abl and MLL fusion genes were observed in 16 (29.1%), 3(5.5%) and 2(3.6%) cases, respectively. (3) Cytogenetic aberration was observed in 56 of total 90 ALL cases (62.2%).

CONCLUSIONS: Cytogenetic changes are common in childhood ALL. Conventional cytogenetic study could reliably detected chromosomal abnormalities for ALL with assessable metaphase. FISH should be used as a complementary method for ALL patients who have poor chromosomal morphology or no metaphase cells, and combination of both methods can improve the detection rate of genetic abnormalities in childhood leukemia.

Medienart:

Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:33

Enthalten in:

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 33(2012), 4 vom: 04. Apr., Seite 282-5

Sprache:

Chinesisch

Beteiligte Personen:

Liu, Qing [VerfasserIn]
Jiang, Hui [VerfasserIn]
Sun, Heng-juan [VerfasserIn]
Song, Yi-ju [VerfasserIn]
Bao, Li-ming [VerfasserIn]

Themen:

149025-06-9
EC 2.7.10.2
English Abstract
Fusion Proteins, bcr-abl
Journal Article
Myeloid-Lymphoid Leukemia Protein

Anmerkungen:

Date Completed 29.08.2013

Date Revised 21.11.2013

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM219313458